Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 319


The IL-17B-IL-17 receptor B pathway promotes resistance to paclitaxel in breast tumors through activation of the ERK1/2 pathway.

Laprevotte E, Cochaud S, du Manoir S, Lapierre M, Dejou C, Philippe M, Giustiniani J, Frewer KA, Sanders AJ, Jiang WG, Michaud HA, Colombo PE, Bensussan A, Alberici G, Bastid J, Eliaou JF, Bonnefoy N.

Oncotarget. 2017 Dec 6;8(69):113360-113372. doi: 10.18632/oncotarget.23008. eCollection 2017 Dec 26.


Truncating mutations of TP53AIP1 gene predispose to cutaneous melanoma.

Benfodda M, Gazal S, Descamps V, Basset-Seguin N, Deschamps L, Thomas L, Lebbe C, Saiag P, Zanetti R, Sacchetto L, Chiorino G, Scatolini M, Grandchamp B, Bensussan A, Soufir N.

Genes Chromosomes Cancer. 2018 Jan 23. doi: 10.1002/gcc.22528. [Epub ahead of print]


KIR3DL2 expression in patients with adult T-cell lymphoma/leukemia.

Hurabielle C, Leboeuf C, Ram-Wolff C, Meignin V, Rivet J, Vignon-Pennamen MD, Bonnafous C, Sicard H, Fite C, Raffoux E, Arnulf B, Oksenhendler E, de Fontbrune FS, de Latour RP, Socié G, Bouaziz JD, Lebbé C, Bensussan A, Janin A, Bagot M, Battistella M.

Br J Dermatol. 2018 Jan 8. doi: 10.1111/bjd.16322. [Epub ahead of print]


Human Cardiac-Derived Stem/Progenitor Cells Fine-Tune Monocyte-Derived Descendants Activities toward Cardiac Repair.

Dam N, Hocine HR, Palacios I, DelaRosa O, Menta R, Charron D, Bensussan A, El Costa H, Jabrane-Ferrat N, Dalemans W, Lombardo E, Al-Daccak R.

Front Immunol. 2017 Oct 26;8:1413. doi: 10.3389/fimmu.2017.01413. eCollection 2017.


KIR3DL2 expression in cutaneous T-cell lymphomas: expanding the spectrum for KIR3DL2 targeting.

Battistella M, Leboeuf C, Ram-Wolff C, Hurabielle C, Bonnafous C, Sicard H, Bensussan A, Bagot M, Janin A.

Blood. 2017 Dec 28;130(26):2900-2902. doi: 10.1182/blood-2017-06-792382. Epub 2017 Oct 31. No abstract available.


Corrigendum: Minimizing the risk of allo-sensitization to optimize the benefit of allogeneic cardiac-derived stem/progenitor cells.

Hocine HR, Costa HE, Dam N, Giustiniani J, Palacios I, Loiseau P, Bensussan A, Borlado LR, Charron D, Suberbielle C, Jabrane-Ferrat N, Al-Daccak R.

Sci Rep. 2017 Oct 20;7:46888. doi: 10.1038/srep46888.


Therapeutic Antibodies to KIR3DL2 and Other Target Antigens on Cutaneous T-Cell Lymphomas.

Schmitt C, Marie-Cardine A, Bensussan A.

Front Immunol. 2017 Aug 30;8:1010. doi: 10.3389/fimmu.2017.01010. eCollection 2017. Review.


Nondestructive tissue analysis for ex vivo and in vivo cancer diagnosis using a handheld mass spectrometry system.

Zhang J, Rector J, Lin JQ, Young JH, Sans M, Katta N, Giese N, Yu W, Nagi C, Suliburk J, Liu J, Bensussan A, DeHoog RJ, Garza KY, Ludolph B, Sorace AG, Syed A, Zahedivash A, Milner TE, Eberlin LS.

Sci Transl Med. 2017 Sep 6;9(406). pii: eaan3968. doi: 10.1126/scitranslmed.aan3968.


Up-and-down immunity of pregnancy in humans.

Le Bouteiller P, Bensussan A.

F1000Res. 2017 Jul 25;6:1216. doi: 10.12688/f1000research.11690.1. eCollection 2017. Review.


Chemotherapy treatment induces an increase of autophagy in the luminal breast cancer cell MCF7, but not in the triple-negative MDA-MB231.

Garbar C, Mascaux C, Giustiniani J, Merrouche Y, Bensussan A.

Sci Rep. 2017 Aug 3;7(1):7201. doi: 10.1038/s41598-017-07489-x.


Circulating and skin-derived Sézary cells: clonal but with phenotypic plasticity.

Roelens M, Delord M, Ram-Wolff C, Marie-Cardine A, Alberdi A, Maki G, Homyrda L, Bensussan A, Bagot M, Toubert A, Moins-Teisserenc H.

Blood. 2017 Sep 21;130(12):1468-1471. doi: 10.1182/blood-2017-03-772996. Epub 2017 Jul 31. No abstract available.


Study of gene expression alteration in male androgenetic alopecia: evidence of predominant molecular signalling pathways.

Michel L, Reygagne P, Benech P, Jean-Louis F, Scalvino S, Ly Ka So S, Hamidou Z, Bianovici S, Pouch J, Ducos B, Bonnet M, Bensussan A, Patatian A, Lati E, Wdzieczak-Bakala J, Choulot JC, Loing E, Hocquaux M.

Br J Dermatol. 2017 Nov;177(5):1322-1336. doi: 10.1111/bjd.15577. Epub 2017 Oct 25.


Corrigendum: Minimizing the risk of allo-sensitization to optimize the benefit of allogeneic cardiac-derived stem/progenitor cells.

Hocine HR, Costa HE, Dam N, Giustiniani J, Palacios I, Loiseau P, Bensussan A, Borlado LR, Charron D, Suberbielle C, Jabrane-Ferrat N, Al-Daccak R.

Sci Rep. 2017 Mar 16;7:44720. doi: 10.1038/srep44720. No abstract available.


Usefulness of KIR3DL2 to Diagnose, Follow-Up, and Manage the Treatment of Patients with Sézary Syndrome.

Hurabielle C, Thonnart N, Ram-Wolff C, Sicard H, Bensussan A, Bagot M, Marie-Cardine A.

Clin Cancer Res. 2017 Jul 15;23(14):3619-3627. doi: 10.1158/1078-0432.CCR-16-3185. Epub 2017 Jan 24.


PDE4D promotes FAK-mediated cell invasion in BRAF-mutated melanoma.

Delyon J, Servy A, Laugier F, André J, Ortonne N, Battistella M, Mourah S, Bensussan A, Lebbé C, Dumaz N.

Oncogene. 2017 Jun 8;36(23):3252-3262. doi: 10.1038/onc.2016.469. Epub 2017 Jan 16.


Uterine immune profiling for increasing live birth rate: A one-to-one matched cohort study.

Lédée N, Prat-Ellenberg L, Chevrier L, Balet R, Simon C, Lenoble C, Irani EE, Bouret D, Cassuto G, Vitoux D, Vezmar K, Bensussan A, Chaouat G, Petitbarat M.

J Reprod Immunol. 2017 Feb;119:23-30. doi: 10.1016/j.jri.2016.11.007. Epub 2016 Nov 24.


Dermatopulmonary Syndrome Associated With Anti-MDA5 Antibodies After Allogeneic Hematopoietic Stem Cell Transplantation.

Lepelletier C, Bengoufa D, Lyes Z, de Masson A, Chasset F, Jachiet M, Michonneau D, Robin M, Peffault de Latour R, Sicre de Fontbrune F, Tandjaoui-Lambiotte Y, Bensussan A, Rybojad M, Tazi A, Bagot M, Socié G, Bergeron A, Bouaziz JD.

JAMA Dermatol. 2016 Nov 16. doi: 10.1001/jamadermatol.2016.3976. [Epub ahead of print]


Intrinsically aged dermal fibroblasts fail to differentiate into adipogenic lineage.

Brun C, Ly Ka So S, Maginiot F, Bensussan A, Michel L, Larghero J, Wong H, Oddos T, Cras A.

Exp Dermatol. 2016 Nov;25(11):906-909. doi: 10.1111/exd.13080. No abstract available.


MUC1-ARF-A Novel MUC1 Protein That Resides in the Nucleus and Is Expressed by Alternate Reading Frame Translation of MUC1 mRNA.

Chalick M, Jacobi O, Pichinuk E, Garbar C, Bensussan A, Meeker A, Ziv R, Zehavi T, Smorodinsky NI, Hilkens J, Hanisch FG, Rubinstein DB, Wreschner DH.

PLoS One. 2016 Oct 21;11(10):e0165031. doi: 10.1371/journal.pone.0165031. eCollection 2016.


Targeting the Tumor Microenvironment: The Protumor Effects of IL-17 Related to Cancer Type.

Fabre J, Giustiniani J, Garbar C, Antonicelli F, Merrouche Y, Bensussan A, Bagot M, Al-Dacak R.

Int J Mol Sci. 2016 Aug 30;17(9). pii: E1433. doi: 10.3390/ijms17091433. Review.


Identification of CD245 as myosin 18A, a receptor for surfactant A: A novel pathway for activating human NK lymphocytes.

De Masson A, Giustiniani J, Marie-Cardine A, Bouaziz JD, Dulphy N, Gossot D, Validire P, Tazi A, Garbar C, Bagot M, Merrouche Y, Bensussan A.

Oncoimmunology. 2016 Jan 13;5(5):e1127493. doi: 10.1080/2162402X.2015.1127493. eCollection 2016 May.


IL-17E synergizes with EGF and confers in vitro resistance to EGFR-targeted therapies in TNBC cells.

Merrouche Y, Fabre J, Cure H, Garbar C, Fuselier C, Bastid J, Antonicelli F, Al-Daccak R, Bensussan A, Giustiniani J.

Oncotarget. 2016 Aug 16;7(33):53350-53361. doi: 10.18632/oncotarget.10804.


TERT promoter mutations in melanoma render TERT expression dependent on MAPK pathway activation.

Vallarelli AF, Rachakonda PS, André J, Heidenreich B, Riffaud L, Bensussan A, Kumar R, Dumaz N.

Oncotarget. 2016 Aug 16;7(33):53127-53136. doi: 10.18632/oncotarget.10634.


Herbal Medicine for Hot Flushes Induced by Endocrine Therapy in Women with Breast Cancer: A Systematic Review and Meta-Analysis.

Li Y, Zhu X, Bensussan A, Li P, Moylan E, Delaney G, McPherson L.

Evid Based Complement Alternat Med. 2016;2016:1327251. doi: 10.1155/2016/1327251. Epub 2016 Jun 21. Review.


KIR3DL2 (CD158k) is a potential therapeutic target in primary cutaneous anaplastic large-cell lymphoma.

Battistella M, Janin A, Jean-Louis F, Collomb C, Leboeuf C, Sicard H, Bonnafous C, Dujardin A, Ram-Wolff C, Kadin ME, Bensussan A, Bagot M, Michel L.

Br J Dermatol. 2016 Aug;175(2):325-33. doi: 10.1111/bjd.14626. Epub 2016 Jul 13.


[Immunopathology of psoriasis: from bench to bedside].

de Masson A, Bouaziz JD, Battistella M, Bagot M, Bensussan A.

Med Sci (Paris). 2016 Mar;32(3):253-9. doi: 10.1051/medsci/20163203009. Epub 2016 Mar 23. Review. French.


APRIL levels are associated with disease activity in human chronic graft-versus-host disease.

Chasset F, de Masson A, Le Buanec H, Xhaard A, de Fontbrune FS, Robin M, Rybojad M, Parquet N, Brignier AC, Coman T, Bengoufa D, Bergeron A, Peffault de Latour R, Bagot M, Bensussan A, Socié G, Bouaziz JD.

Haematologica. 2016 Jul;101(7):e312-5. doi: 10.3324/haematol.2016.145409. Epub 2016 Mar 18. No abstract available.


Hypoxia and MITF regulate KIT oncogenic properties in melanocytes.

Laugier F, Delyon J, André J, Bensussan A, Dumaz N.

Oncogene. 2016 Sep 22;35(38):5070-7. doi: 10.1038/onc.2016.39. Epub 2016 Mar 14.


Evaluation of Immunophenotypic and Molecular Biomarkers for Sézary Syndrome Using Standard Operating Procedures: A Multicenter Study of 59 Patients.

Boonk SE, Zoutman WH, Marie-Cardine A, van der Fits L, Out-Luiting JJ, Mitchell TJ, Tosi I, Morris SL, Moriarty B, Booken N, Felcht M, Quaglino P, Ponti R, Barberio E, Ram-Wolff C, Jäntti K, Ranki A, Bernengo MG, Klemke CD, Bensussan A, Michel L, Whittaker S, Bagot M, Tensen CP, Willemze R, Vermeer MH.

J Invest Dermatol. 2016 Jul;136(7):1364-1372. doi: 10.1016/j.jid.2016.01.038. Epub 2016 Feb 28.


Trem-1 is not crucial in psoriasiform imiquimod-induced skin inflammation in mice.

Joffre J, Hau E, Zeboudj L, Laurans L, Battistella M, Boufenzer A, Masson A, Le Buanec H, Cochaud S, Bagot M, Bensussan A, Gibot S, Bouaziz JD, Ait-Oufella H.

Exp Dermatol. 2016 May;25(5):400-2. doi: 10.1111/exd.12944. No abstract available.


The Uterine Immune Profile May Help Women With Repeated Unexplained Embryo Implantation Failure After In Vitro Fertilization.

Lédée N, Petitbarat M, Chevrier L, Vitoux D, Vezmar K, Rahmati M, Dubanchet S, Gahéry H, Bensussan A, Chaouat G.

Am J Reprod Immunol. 2016 Mar;75(3):388-401. doi: 10.1111/aji.12483. Epub 2016 Jan 18.


Expression of Sézary Biomarkers in the Blood of Patients with Erythrodermic Mycosis Fungoides.

Hurabielle C, Michel L, Ram-Wolff C, Battistella M, Jean-Louis F, Beylot-Barry M, d'Incan M, Bensussan A, Bagot M.

J Invest Dermatol. 2016 Jan;136(1):317-20. doi: 10.1038/JID.2015.360. No abstract available.


PARKIN Inactivation Links Parkinson's Disease to Melanoma.

Hu HH, Kannengiesser C, Lesage S, André J, Mourah S, Michel L, Descamps V, Basset-Seguin N, Bagot M, Bensussan A, Lebbé C, Deschamps L, Saiag P, Leccia MT, Bressac-de-Paillerets B, Tsalamlal A, Kumar R, Klebe S, Grandchamp B, Andrieu-Abadie N, Thomas L, Brice A, Dumaz N, Soufir N.

J Natl Cancer Inst. 2015 Dec 17;108(3). doi: 10.1093/jnci/djv340. Print 2016 Mar.


CD Nomenclature 2015: Human Leukocyte Differentiation Antigen Workshops as a Driving Force in Immunology.

Engel P, Boumsell L, Balderas R, Bensussan A, Gattei V, Horejsi V, Jin BQ, Malavasi F, Mortari F, Schwartz-Albiez R, Stockinger H, van Zelm MC, Zola H, Clark G.

J Immunol. 2015 Nov 15;195(10):4555-63. doi: 10.4049/jimmunol.1502033.


Phenotypic and functional changes in dermal primary fibroblasts isolated from intrinsically aged human skin.

Brun C, Jean-Louis F, Oddos T, Bagot M, Bensussan A, Michel L.

Exp Dermatol. 2016 Feb;25(2):113-9. doi: 10.1111/exd.12874. Epub 2016 Jan 11.


A novel targeted immunotherapy for CTCL is on its way: Anti-KIR3DL2 mAb IPH4102 is potent and safe in non-clinical studies.

Sicard H, Bonnafous C, Morel A, Bagot M, Bensussan A, Marie-Cardine A.

Oncoimmunology. 2015 Jun 1;4(9):e1022306. eCollection 2015 Sep.


Expression of Sézary Biomarkers in the Blood of Erythrodermic Mycosis Fungoides Patients.

Hurabielle C, Michel L, Ram-Wolff C, Battistella M, Jean-Louis F, Beylot-Barry M, d'Incan M, Bensussan A, Bagot M.

J Invest Dermatol. 2015 Sep 15. doi: 10.1038/jid.2015.360. [Epub ahead of print] No abstract available.


RICTOR involvement in the PI3K/AKT pathway regulation in melanocytes and melanoma.

Laugier F, Finet-Benyair A, André J, Rachakonda PS, Kumar R, Bensussan A, Dumaz N.

Oncotarget. 2015 Sep 29;6(29):28120-31. doi: 10.18632/oncotarget.4866.


Evidence of Th1, Th17 and Tc17 cells in psoriasiform chronic graft-versus-host disease.

Chasset F, Le Buanec H, Sicre de Fontbrune F, de Masson A, Rivet J, Bergeron A, Bagot M, Socié G, Bensussan A, Bouaziz JD.

Exp Dermatol. 2016 Jan;25(1):64-5. doi: 10.1111/exd.12857. Epub 2015 Nov 2. No abstract available.


Autophagy is decreased in triple-negative breast carcinoma involving likely the MUC1-EGFR-NEU1 signalling pathway.

Garbar C, Mascaux C, Giustiniani J, Salesse S, Debelle L, Antonicelli F, Merrouche Y, Bensussan A.

Int J Clin Exp Pathol. 2015 May 1;8(5):4344-55. eCollection 2015.


CD39: A complementary target to immune checkpoints to counteract tumor-mediated immunosuppression.

Bonnefoy N, Bastid J, Alberici G, Bensussan A, Eliaou JF.

Oncoimmunology. 2015 Feb 3;4(5):e1003015. eCollection 2015 May.


IL-17A and its homologs IL-25/IL-17E recruit the c-RAF/S6 kinase pathway and the generation of pro-oncogenic LMW-E in breast cancer cells.

Mombelli S, Cochaud S, Merrouche Y, Garbar C, Antonicelli F, Laprevotte E, Alberici G, Bonnefoy N, Eliaou JF, Bastid J, Bensussan A, Giustiniani J.

Sci Rep. 2015 Jul 8;5:11874. doi: 10.1038/srep11874.


Deficient regulatory B cells in human chronic graft-versus-host disease.

de Masson A, Socié G, Bagot M, Bensussan A, Bouaziz JD.

Oncoimmunology. 2015 Apr 1;4(7):e1016707. eCollection 2015 Jul.


Lack of evidence that HACE1 is not a tumor suppressor gene in NKTCL: to the editor-in-chief. Authors' reply.

Schmitt C, Sako N, Bagot M, Bensussan A.

Am J Pathol. 2015 Apr;185(4):1168. doi: 10.1016/j.ajpath.2015.02.001. No abstract available.


Colony Stimulating Factors 1, 2, 3 and early pregnancy steps: from bench to bedside.

Rahmati M, Petitbarat M, Dubanchet S, Bensussan A, Chaouat G, Ledee N.

J Reprod Immunol. 2015 Jun;109:1-6. doi: 10.1016/j.jri.2015.01.005. Epub 2015 Feb 11. Review.


CD24(hi)CD27⁺ and plasmablast-like regulatory B cells in human chronic graft-versus-host disease.

de Masson A, Bouaziz JD, Le Buanec H, Robin M, O'Meara A, Parquet N, Rybojad M, Hau E, Monfort JB, Branchtein M, Michonneau D, Dessirier V, Sicre de Fontbrune F, Bergeron A, Itzykson R, Dhédin N, Bengoufa D, Peffault de Latour R, Xhaard A, Bagot M, Bensussan A, Socié G.

Blood. 2015 Mar 12;125(11):1830-9. doi: 10.1182/blood-2014-09-599159. Epub 2015 Jan 20.


Prognostic factors in operable breast cancer treated with neoadjuvant chemotherapy: towards a quantification of residual disease.

Mombelli S, Kwiatkowski F, Abrial C, Wang-Lopez Q, de Boissieu P, Garbar C, Bensussan A, Curé H.

Oncology. 2015;88(5):261-72. doi: 10.1159/000368557. Epub 2015 Jan 8.


KIR3DL2 is a coinhibitory receptor on Sézary syndrome malignant T cells that promotes resistance to activation-induced cell death.

Thonnart N, Caudron A, Legaz I, Bagot M, Bensussan A, Marie-Cardine A.

Blood. 2014 Nov 20;124(22):3330-2. doi: 10.1182/blood-2014-09-598995. No abstract available.


Inhibition of CD39 enzymatic function at the surface of tumor cells alleviates their immunosuppressive activity.

Bastid J, Regairaz A, Bonnefoy N, Déjou C, Giustiniani J, Laheurte C, Cochaud S, Laprevotte E, Funck-Brentano E, Hemon P, Gros L, Bec N, Larroque C, Alberici G, Bensussan A, Eliaou JF.

Cancer Immunol Res. 2015 Mar;3(3):254-65. doi: 10.1158/2326-6066.CIR-14-0018. Epub 2014 Nov 17.


IPH4102, a humanized KIR3DL2 antibody with potent activity against cutaneous T-cell lymphoma.

Marie-Cardine A, Viaud N, Thonnart N, Joly R, Chanteux S, Gauthier L, Bonnafous C, Rossi B, Bléry M, Paturel C, Bensussan A, Bagot M, Sicard H.

Cancer Res. 2014 Nov 1;74(21):6060-70. doi: 10.1158/0008-5472.CAN-14-1456.

Supplemental Content

Loading ...
Support Center